Home > Healthcare > Medical Devices > Diagnostic Devices > Non-invasive Helicobacter Pylori Testing Market

Non-invasive Helicobacter Pylori Testing Market Trends

Report ID: GMI9134
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Non-invasive Helicobacter Pylori Testing Market Trends

The latest advancements in laboratory serological assay for non-invasive Helicobacter pylori testing include the development of high throughput diagnostic systems for local diagnostic testing. These systems are designed to improve the efficiency and accuracy of helicobacter pylori testing.

Molecular methods such as real-time PCR assays, are also being used for the detection of H-pylori in stool specimens, with high sensitivity and specificity. These methods can also be used to detect antibiotic resistance, which is important for the effective treatment of H-pylori infection.
In addition, there have been advancements in the use of point-of-care (POC) tests for the detection of H. pylori infection, such as lateral flow assays and immunochromatographic assays (ICAs), that can provide rapid results and are easy to use in clinical settings. These advancements enable the growing preferences for non-invasive testing approach for diagnosis of H-pylori.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Non-invasive helicobacter pylori testing market size was USD 273.6 million in 2023 and is expected to register 7.1% CAGR from 2024-2032 owing to the rising prevalence of gastric and duodenal illnesses, such as gastric cancer and peptic ulcer disease, worldwide.

Non-invasive helicobacter pylori testing industry from the serologic test segment recorded USD 110.7 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to being convenient and preferable to patients.

North America non-invasive helicobacter pylori testing industry reached USD 97.7 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to favorable reimbursement policies and the region's higher healthcare expenditure.

Abbott, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, certest Biotech srl, Fisher Scientific, Gulf Coast Scientific, Meridian Bioscience Inc., Quidel Corporation, and Tri-Med, are some of the major non-invasive helicobacter pylori testing companies worldwide.